SBC is delighted to Welcome Sentinal4D – our latest Occupier to check into the Lab Hotel!
Sentinal4D is deploying a biology-first, data-driven approach with focus on phenotypic-based drug discovery. By harnessing AI-powered 3D cell imaging, they are transforming drug discovery and development, accelerating the journey of oncology groundbreaking treatments from lab to clinic.
Georgia Mitsi – CEO and Co-Founder, said: “We are excited and grateful to have the opportunity to make SBC Sentinal4D’s home after our recent transition from The Institute of Cancer Research (ICR). SBC has created an ecosystem of high potential start ups and access to much needed resources which fosters innovation and promotes partnerships and collaborations. Being surrounded by like-minded individuals and other companies that are trying to solve big unmet needs with cutting edge technologies is paramount for our success.”
Excited to see the team grow and scale – welcome to the campus!
